Designed for women and men, it supports daily oral use with a clean-label approach to appetite suppressant support, fat burn, energy boost, digestive health, and metabolic wellness
CagriSema: This Novo Nordisk combination is a fixed-dose co-formulation of the GLP-1 agonist semaglutide and the long-acting amylin analogue cagrilintide
Needle Anxiety When choosing a GLP-1, consider if youre more likely to stick to a pill or an injection
Ro recently published the first study to evaluate both the long-term weight loss and safety outcomes of treatment with semaglutide via telehealth
The alcohol swab is not medical theater
Gastrointestinal Symptoms Nausea, bloating, and gastrointestinal discomfort are common side effects of GLP-1 medications, particularly early in treatment or after dose increases